KRAS and melanoma: These subtypes are represented by BRAF mutant melanomas, which account for approximately 50% of melanomas; NRAS-, KRAS-, and HRAS-mutant melanomas, which are about 25%; NF1-mutant melanomas (15% of melanomas); and triple-wild-type melanomas, which account for the remaining 10% of cases [30].